Glaxo in bid for Pfizer's Listerine business

GlaxoSmithKline was today at the centre of speculation linking it to an €11.6bn bid for Pfizer’s Listerine-to-Sudafed consumer healthcare arm.

Glaxo in bid for Pfizer's Listerine business

GlaxoSmithKline was today at the centre of speculation linking it to an €11.6bn bid for Pfizer’s Listerine-to-Sudafed consumer healthcare arm.

Such a move would transform Glaxo into the world’s biggest maker of non-prescription drugs, as well as the second largest prescription drugs supplier.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited